Country: Canada
Language: English
Source: Health Canada
CHLORHEXIDINE GLUCONATE
AMD MEDICOM INC
A01AB03
CHLORHEXIDINE
0.12%
MOUTHWASH
CHLORHEXIDINE GLUCONATE 0.12%
BUCCAL
500ML/4L
Prescription
MISCELLANEOUS ANTI-INFECTIVES
Active ingredient group (AIG) number: 0107629007; AHFS:
APPROVED
1999-06-29
DentiCare™ Chlorhexidine Gluconate Oral Rinse 0.12% Product Monograph Page 1 of 10 PRODUCT MONOGRAPH PR DENTICARE ™ CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE ANTIGINGIVITIS ORAL RINSE AMD Medicom Inc. 2555 Chemin de l’Aviation Pointe-Claire, Montréal, Québec Canada, H9P 2Z2 www.medicom.ca Submission Control No: 223628 Date of Preparation: March 28, 2019 DentiCare™ Chlorhexidine Gluconate Oral Rinse 0.12% Product Monograph Page 2 of 10 PRODUCT MONOGRAPH DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% 0.12% Chlorhexidine Gluconate THERAPEUTIC CLASSIFICATION Antigingivitis Oral Rinse ACTION AND CLINICAL PHARMACOLOGY DentiCare Chlorhexidine Gluconate Oral Rinse 0.12% provides antimicrobial activity during oral rinsing which is maintained between rinsings. Microbiologic sampling of plaque has shown a general reduction of both aerobic and anaerobic bacterial counts through six months’ clinical use of 0.12% chlorhexidine gluconate oral rinse. Rinsing with 0.12% chlorhexidine gluconate oral rinse inhibits the build-up and maturation of plaque by reducing certain microbes regarded as gingival pathogens, thereby reducing gingivitis. 0.12% chlorhexidine gluconate oral rinse provides antimicrobial activity during rinsing and for several hours thereafter. No significant changes in bacterial sensitivity, overgrowth of potentially opportunistic organisms or other adverse changes in the oral microbial flora were observed following the use of a 0.12% chlorhexidine gluconate oral rinse for six months. Three months after discontinued use, the number of bacteria in plaque had returned to pretreatment levels and sensitivity of plaque bacteria to chlorhexidine gluconate remained unchanged. Studies conducted with human subjects and animals demonstrate that any ingested chlorhexidine gluconate is poorly absorbed in the gastrointestinal tract. Excretion of chlorhexidine gluconate occurred primarily through the feces (approximately 90%). Less than 1% of the chlorhexidine gluconate ing Read the complete document